# Study of Pharmacotherapy of Psychotic Depression

> **NCT00056472** · PHASE3 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 259 (actual)

## Conditions studied

- Major Depressive Disorder With Psychotic Features

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Sertraline
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00056472
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2013-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056472, "Study of Pharmacotherapy of Psychotic Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00056472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*